Search research articles
Contact Us
Filters
Showing results (91-100 of 190) with videos related to
Page
of 19
Sort By:
Chemical Communications (Cambridge, England)
|
September 11, 2024
Modulating the guest binding ability within mixed-coordination geometry [Pd(μ-L)<sub>4</sub>RuCl<sub>2</sub>]<sup>2+</sup> and [Pd(μ-L)<sub>4</sub>Pt]<sup>4+</sup> cage architectures
Hayden B Gearing, Tilo Söhnel, Paul Young, et al.
Dalton Transactions (Cambridge, England : 2003)
|
March 29, 2006
Redox behavior of tumor-inhibiting ruthenium(III) complexes and effects of physiological reductants on their binding to GMP
Petra Schluga, Christian G Hartinger, Alexander Egger, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
July 27, 2018
Understanding the interactions of diruthenium anticancer agents with amino acids
Alexey A Nazarov, Maria-Grazia Mendoza-Ferri, Muhammad Hanif, et al.
Electrophoresis
|
January 28, 2006
Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins
Kasia Polec-Pawlak, Jan K Abramski, Olga Semenova, et al.
Organic & Biomolecular Chemistry
|
January 28, 2015
Physicochemical studies on the copper(II) binding by glycated collagen telopeptides
Meder Kamalov, Paul W R Harris, Christian G Hartinger, et al.
Journal of Inorganic Biochemistry
|
September 17, 2017
Anticancer Ru(η<sup>6</sup>-p-cymene) complexes of 2-pyridinecarbothioamides: A structure-activity relationship study
Jahanzaib Arshad, Muhammad Hanif, Sanam Movassaghi, et al.
Molecules (Basel, Switzerland)
|
February 10, 2021
Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide
Jahanzaib Arshad, Kelvin K H Tong, Sanam Movassaghi, et al.
Chemmedchem
|
March 7, 2007
A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
Isabella Berger, Alexey A Nazarov, Christian G Hartinger, et al.
Inorganic Chemistry
|
October 14, 2022
Impact of Coordination Mode and Ferrocene Functionalization on the Anticancer Activity of N-Heterocyclic Carbene Half-Sandwich Complexes
Kelvin K H Tong, Mie Riisom, Euphemia Leung, et al.
Dalton Transactions (Cambridge, England : 2003)
|
May 30, 2014
Aqueous chemistry and antiproliferative activity of a pyrone-based phosphoramidate Ru(arene) anticancer agent
Samuel M Meier, Maria S Novak, Wolfgang Kandioller, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 190) with videos related to
Sort By:
Page
of 19
Chemical Communications (Cambridge, England)
|
September 11, 2024
Modulating the guest binding ability within mixed-coordination geometry [Pd(μ-L)<sub>4</sub>RuCl<sub>2</sub>]<sup>2+</sup> and [Pd(μ-L)<sub>4</sub>Pt]<sup>4+</sup> cage architectures
Hayden B Gearing, Tilo Söhnel, Paul Young, et al.
Dalton Transactions (Cambridge, England : 2003)
|
March 29, 2006
Redox behavior of tumor-inhibiting ruthenium(III) complexes and effects of physiological reductants on their binding to GMP
Petra Schluga, Christian G Hartinger, Alexander Egger, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
July 27, 2018
Understanding the interactions of diruthenium anticancer agents with amino acids
Alexey A Nazarov, Maria-Grazia Mendoza-Ferri, Muhammad Hanif, et al.
Electrophoresis
|
January 28, 2006
Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins
Kasia Polec-Pawlak, Jan K Abramski, Olga Semenova, et al.
Organic & Biomolecular Chemistry
|
January 28, 2015
Physicochemical studies on the copper(II) binding by glycated collagen telopeptides
Meder Kamalov, Paul W R Harris, Christian G Hartinger, et al.
Journal of Inorganic Biochemistry
|
September 17, 2017
Anticancer Ru(η<sup>6</sup>-p-cymene) complexes of 2-pyridinecarbothioamides: A structure-activity relationship study
Jahanzaib Arshad, Muhammad Hanif, Sanam Movassaghi, et al.
Molecules (Basel, Switzerland)
|
February 10, 2021
Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide
Jahanzaib Arshad, Kelvin K H Tong, Sanam Movassaghi, et al.
Chemmedchem
|
March 7, 2007
A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
Isabella Berger, Alexey A Nazarov, Christian G Hartinger, et al.
Inorganic Chemistry
|
October 14, 2022
Impact of Coordination Mode and Ferrocene Functionalization on the Anticancer Activity of N-Heterocyclic Carbene Half-Sandwich Complexes
Kelvin K H Tong, Mie Riisom, Euphemia Leung, et al.
Dalton Transactions (Cambridge, England : 2003)
|
May 30, 2014
Aqueous chemistry and antiproliferative activity of a pyrone-based phosphoramidate Ru(arene) anticancer agent
Samuel M Meier, Maria S Novak, Wolfgang Kandioller, et al.
Page
of 19